Solu-cortef and Ganciclovir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Solu-cortef (hydrocortisone sodium succinate) and Ganciclovir (ganciclovir). Common drug interactions include headache among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Solu-cortef and Ganciclovir. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Solu-cortef?

Solu-cortef has active ingredients of hydrocortisone sodium succinate. eHealthMe is studying from 7,983 Solu-cortef users. Check the latest studies of Solu-cortef.

What is Ganciclovir?

Ganciclovir has active ingredients of ganciclovir. eHealthMe is studying from 6,370 Ganciclovir users. Check the latest studies of Ganciclovir.



On Jul, 09, 2026

36 people who take Solu-cortef and Ganciclovir together, and have interactions are studied.

Solu-cortef and Ganciclovir drug interactions.

What are the common drug interactions of Solu-Cortef and Ganciclovir, by gender? *:

female:

  1. Headache (pain in head)
  2. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)
  3. Hypoproteinaemia (too little prolactin circulating in the blood)
  4. Lipids increased (excess lipid in body)
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Muscular weakness (muscle weakness)
  7. Myositis (inflammation of the muscles)
  8. Pain
  9. Pain in extremity
  10. Pancreatitis acute (sudden inflammation of pancreas)

male:

  1. Pyrexia (fever)
  2. Pneumonia
  3. Somnolence (a state of near-sleep, a strong desire for sleep)
  4. Vomiting
  5. White blood cell count decreased
  6. Cytomegalovirus infection
  7. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  8. Agitation (state of anxiety or nervous excitement)
  9. Depressed level of consciousness
  10. Fungal infection

What are the common drug interactions of Solu-Cortef and Ganciclovir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Neurological decompensation (inability of brain to maintain proper function)
  2. Nystagmus (a condition of involuntary eye movement)
  3. Oxygen saturation decreased
  4. Partial seizures (seizures which affect only a part of the brain at onset)
  5. Pleural effusion (water on the lungs)
  6. Pneumonia
  7. Pulmonary alveolar haemorrhage (acute bleeding)
  8. Pulmonary mycosis (lung infection caused by yeast-like fungi)
  9. Pulmonary oedema (fluid accumulation in the lungs)
  10. Respiratory disorder (respiratory disease)

10-19:

  1. Ascites (accumulation of fluid in the abdominal cavity)
  2. Blood immunoglobulin g decreased
  3. Abulia (lack of will or initiative)
  4. Blindness cortical
  5. Blood beta-d-glucan increased
  6. Dehydration (dryness resulting from the removal of water)
  7. Encephalitis (inflammation of the brain)
  8. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  9. Haematuria (presence of blood in urine)
  10. Muscular weakness (muscle weakness)

20-29:

  1. Liver transplant rejection (failure of liver transplant)
  2. Abdominal infection
  3. Bacteraemia (presence of bacteria in the blood)
  4. Cytomegalovirus infection
  5. Gastrointestinal anastomotic leak (breakdown at the site of a post-surgical closure of a stomach and intestine)
  6. Hepatic vein stenosis
  7. Influenza
  8. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
  9. Peritonitis bacterial (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs by bacterial)
  10. Post procedural bile leak

30-39:

  1. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  2. Blood creatinine increased
  3. Blood urea increased
  4. C-reactive protein increased
  5. Renal impairment (severely reduced kidney function)

40-49:

  1. Herpes simplex (herpes simplex is a common viral infection)
  2. Ileal ulcer
  3. Pyrexia (fever)
  4. Transplant rejection (a transplant material is not worked)

50-59:

  1. Pneumonia
  2. Anaemia (lack of blood)
  3. Cytomegalovirus chorioretinitis (infection of choroid and retina of the eye from virus)
  4. Decreased appetite
  5. Lactic acidosis (low ph in body tissues)
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Vomiting
  8. White blood cell count decreased
  9. Blood pressure decreased
  10. Klebsiella infection

60+:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Pyrexia (fever)
  4. Blood beta-d-glucan increased
  5. Enterococcal infection
  6. Fungal infection
  7. Graft versus host disease in skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin)
  8. Therapeutic response decreased (less preventive response)
  9. Cerebral haemorrhage (bleeding within the brain)
  10. Chills (felling of cold)

What are the existing conditions these people have? *

  1. Cytomegalovirus Infection: 11 people, 30.56%
  2. Fever: 7 people, 19.44%
  3. Adult T-Cell Lymphoma/leukaemia (cancer of the immune system's own t-cells): 7 people, 19.44%
  4. Insomnia (sleeplessness): 7 people, 19.44%
  5. Constipation: 7 people, 19.44%
  6. Infusion Related Reaction: 5 people, 13.89%
  7. Bone Marrow Conditioning Regimen: 5 people, 13.89%
  8. Adrenal Insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids): 4 people, 11.11%
  9. Pain: 4 people, 11.11%
  10. High Blood Pressure: 4 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Solu-cortef and Ganciclovir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Solu-cortef and Ganciclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Solu-cortef:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ganciclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Solu-cortef and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ganciclovir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydrocortisone sodium succinate and ganciclovir (the active ingredients of Solu-cortef and Ganciclovir, respectively), and Solu-cortef and Ganciclovir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: